Colibri Heart Valve LLC has developed a pre-packaged and sterilized aortic heart valve that it thinks will further propel the transcatheter aortic heart valve implantation (TAVI) market. Its ready-for-use device has a profile that is roughly 20% to 40% less than the current market leaders, so patients with smaller femoral arteries who are currently excluded can benefit from TAVI.
EU member states have issued a consensus statement on the urgent need to build momentum to tackle governance and centralization issues as part of much-needed reform of the EU medtech regulatory system.
A deep-learning AI-based retinal image scanning tool can predict the risk of cardiovascular events over a 10-year period with 70% accuracy. The test is comparable to routine GP health checks, researchers from the University of Dundee have shown.